Moneycontrol PRO

business

US FDA issues in pharma space may end soon: Morgan Stanley

Sameer Baisiwala, pharmaceutical and property analyst at Morgan Stanley, feels pharmaceuticals space is a good bet given the recent EIRs issued to domestic pharma companies by the regulator.

first published: Jun 1, 2016 10:53 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347